X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (69) 69
index medicus (55) 55
female (46) 46
oncology (36) 36
middle aged (34) 34
aged (30) 30
male (27) 27
aged, 80 and over (19) 19
breast cancer (18) 18
cancer (17) 17
adult (16) 16
pathology (15) 15
care and treatment (14) 14
chemotherapy (14) 14
immunohistochemistry (14) 14
treatment outcome (13) 13
tumors (13) 13
analysis (12) 12
breast neoplasms - pathology (11) 11
prognosis (11) 11
expression (10) 10
risk factors (10) 10
health aspects (9) 9
risk (9) 9
surgery (9) 9
medicine, general & internal (8) 8
mortality (8) 8
breast neoplasms - drug therapy (7) 7
breast neoplasms - genetics (7) 7
breast neoplasms - metabolism (7) 7
carcinoma (7) 7
follow-up studies (7) 7
internal medicine (7) 7
medicine (7) 7
metastasis (7) 7
patients (7) 7
research (7) 7
research article (7) 7
retrospective studies (7) 7
therapy (7) 7
adenocarcinoma - pathology (6) 6
breast neoplasms - surgery (6) 6
cell line, tumor (6) 6
e-cadherin (6) 6
elderly (6) 6
logistic models (6) 6
lymph nodes - pathology (6) 6
medical research (6) 6
medicine & public health (6) 6
neoplasm staging (6) 6
radiotherapy (6) 6
usage (6) 6
animals (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
biomarkers, tumor - analysis (5) 5
biopsy (5) 5
diagnosis (5) 5
drug resistance (5) 5
gene expression regulation, neoplastic (5) 5
genetic aspects (5) 5
hematology (5) 5
lymphatic metastasis (5) 5
mice (5) 5
neoadjuvant therapy (5) 5
neoplasms (5) 5
neoplasms. tumors. oncology. including cancer and carcinogens (5) 5
prevalence (5) 5
prospective studies (5) 5
receptor, erbb-2 - metabolism (5) 5
survival (5) 5
tumor cells, cultured (5) 5
validation (5) 5
young adult (5) 5
age (4) 4
aged patients (4) 4
antineoplastic agents - therapeutic use (4) 4
breast neoplasms - radiotherapy (4) 4
cancer research (4) 4
cancer therapies (4) 4
case report (4) 4
chemotherapy, adjuvant (4) 4
colon cancer (4) 4
combined modality therapy (4) 4
drug therapy (4) 4
further section · weitere sektionen (4) 4
genetics (4) 4
hospital mortality (4) 4
impact (4) 4
lymph-nodes (4) 4
mastectomy (4) 4
metastases (4) 4
mutations (4) 4
neoplasm recurrence, local - pathology (4) 4
obstetrics & gynecology (4) 4
outcomes (4) 4
polymerase chain reaction (4) 4
population (4) 4
predictive value of tests (4) 4
radiology, nuclear medicine & medical imaging (4) 4
trial (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Galimberti, Viviana and Cole, Bernard F and Viale, Giuseppe and Veronesi, Paolo and Vicini, Elisa and Intra, Mattia and Mazzarol, Giovanni and Massarut, Samuele and Zgajnar, Janez and Taffurelli, Mario and Littlejohn, David and Knauer, Michael and Tondini, Carlo and Di Leo, Angelo and Colleoni, Marco and Regan, Meredith M and Coates, Alan S and Gelber, Richard D and Goldhirsch, Aron and Boyle, Fran and Jerusalem, Guy and Stahel, Rolf and Aebi, Stefan and Green, Michael and Karlsson, Per and Kössler, Ingrid and Láng, Istvan and Hiltbrunner, Anita and Bernhard, Jürg and Fournarakou, Stamatina and Kammler, Roswitha and Maibach, Rudolf and Rabaglio, Manuela and Ribi, Karin and Roschitzki, Heidi and Roux, Susanne and Ruepp, Barbara and Mahoney, Caitlin and Price, Karen and Blacher, Lynette and Scolese, Tara and Scott, Karolyn and Lippert, Sandra and Zielinski, Theresa and Mastropasqua, Mauro and Andrighetto, Stefania and Dell'Orto, Patrizia and Renne, Giuseppe and Pruneri, Giancarlo and Dellapasqua, Silvia and Iorfida, Monica and Cancello, Giuseppe and Montagna, Emilia and Cardillo, Anna and Peruzzotti, Giulia and Ghisini, Raffaella and Luini, Alberto and Veronesi, Umberto and Intra, Mattia and Gentilini, Oreste and Zurrida, Stefano and Curigliano, Giuseppe and Nole, Franco and Orecchia, Roberto and Leonardi, Marisa Cristina and Baratella, Paola and Chifu, Camelia and Sargenti, Manuela and Crivellari, Diana and Morassut, Sandro and Mileto, Mario and Piccoli, Erica and Veronesi, Andreas and Magri, Marisa Donatella and Buonadonna, Angelo and Candiani, Ezio and Carbone, Antonino and Perin, Tiziana and Volpe, Rachele and Roncadin, Mario and Arcicasa, Mauro and Coran, Francesco and Lagrassa, Manuela and Recalcati, Angelo and Limonta, Maria Emanuela and Tricomi, Paolo and Fenaroli, Privato and Candiago, Elisabetta and Cattaneo, Laura and Gianatti, Alberto and Santini, Donatella and Maweja, Sylvie and Delvenne, Philippe and Rorive, Andrée and Collignon, Joëlle and Garbay, Jean-Remi and Mathieu, Marie-Christine and Galatius, Hanne and Hoffmann, Jack and Schousen, Peer and ... and International Breast Cancer Study Group Trial 23-01 and Int Breast Canc Study Grp Trial 23
The Lancet Oncology, ISSN 1470-2045, 10/2018, Volume 19, Issue 10, pp. 1385 - 1393
We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial comparing disease-free survival in patients with breast cancer with one or more... 
SURGERY | WOMEN | MULTICENTER | METASTASIS | ONCOLOGY | LYMPH-NODES | BIOPSY | RECURRENCE | EORTC 10981-22023 AMAROS | Care and treatment | Cancer patients | Breast cancer | Analysis | Surgery
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 9, pp. 1404 - 1410
Purpose To centrally assess estrogen receptor (ER) and progesterone receptor (PgR) levels by immunohistochemistry and investigate their predictive value for... 
SUBSETS | RANDOMIZED-TRIALS | ONCOLOGY | CHEMOTHERAPY | CLINICAL-TRIALS | Immunohistochemistry | Breast Neoplasms - surgery | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Menopause | Middle Aged | Receptors, Estrogen - analysis | Tamoxifen - administration & dosage | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Antineoplastic Agents, Hormonal - therapeutic use | Neoplasms, Hormone-Dependent - chemistry | Adult | Female | Chemotherapy, Adjuvant | Goserelin - administration & dosage | Biomarkers, Tumor - analysis | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Neoplasms, Hormone-Dependent - drug therapy | Index Medicus | Estrogen | Hormonal | Breast Neoplasms | Tumor Markers | Neoplasms | Hormone-Dependent | Receptors | administration & dosage | Adjuvant | Methotrexate | Fluorouracil | chemistry | drug therapy | Antineoplastic Agents | Antineoplastic Combined Chemotherapy Protocols | Biological | analysis | Tamoxifen | Chemotherapy | Cyclophosphamide | Progesterone | Cancer and Oncology | therapeutic use | Goserelin | Cancer och onkologi | surgery
Journal Article
Cell Death and Differentiation, ISSN 1350-9047, 04/2018, Volume 25, Issue 12, pp. 1 - 2180
Inactivation of p53 contributes significantly to the dismal prognosis of breast tumors, most notably triple-negative breast cancers (TNBCs). How the relief... 
EPITHELIAL-MESENCHYMAL TRANSITION | MICRORNA-30A | MOLECULAR PORTRAITS | BIOCHEMISTRY & MOLECULAR BIOLOGY | E-CADHERIN | EXPRESSION | TUMOR-SUPPRESSOR P53 | CELLULAR PLASTICITY | FEEDBACK LOOP | FAMILY | SNAIL | CELL BIOLOGY | Prognosis | Mesenchyme | p53 Protein | miRNA | Breast cancer | Drug resistance | Cell migration | Lymph nodes | Tumors | Cell adhesion & migration
Journal Article
Genes, Chromosomes and Cancer, ISSN 1045-2257, 02/2017, Volume 56, Issue 2, pp. 147 - 158
Journal Article
Cell death and differentiation, ISSN 1350-9047, 02/2019, Volume 26, Issue 11, pp. 2493 - 2493
Since publication of the article, the authors were notified by ATCC that the cell line HCC1395 (ATCC® CRL-2324™ Lot 62235652) suffered a "low level of cell... 
p53 Protein | Breast cancer | Contamination
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2/2008, Volume 100, Issue 3, pp. 207 - 212
Several small studies have reported that having a high percentage of breast tumor cells that express the proliferation antigen Ki-67 (ie, a high Ki-67 labeling... 
APOPTOSIS | ONCOLOGY | PROGNOSTIC MARKER | ANTIBODY | RECEPTOR | PROLIFERATIVE ACTIVITY | PRIMARY CHEMOTHERAPY | UNITED-STATES FOOD | MITOTIC INDEX | CARCINOMA | UTILITY | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Tamoxifen - administration & dosage | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Multicenter Studies as Topic | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Biomarkers, Tumor - analysis | Antineoplastic Agents, Hormonal - administration & dosage | Logistic Models | Treatment Outcome | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Ki-67 Antigen - analysis | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Methotrexate - administration & dosage | Aged | Care and treatment | Chemotherapy | Analysis | Breast cancer | Genetic aspects | Health aspects | Risk factors | Endocrinology | Cancer | Clinical trials | Oncology | Tumors | Index Medicus | united-states food | prognostic marker | antibody | receptor | primary chemotherapy | mitotic index | carcinoma | proliferative activity | apoptosis | Cancer and Oncology | Cancer och onkologi | cell-proliferation
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2011, Volume 18, Issue 13, pp. 3686 - 3693
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 10, p. e77035
Journal Article
Internal and Emergency Medicine, ISSN 1828-0447, 2019, pp. 1 - 5
Journal Article
CURRENT CANCER DRUG TARGETS, ISSN 1568-0096, 2018, Volume 18, Issue 5, pp. 410 - 420
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 1460 - 1460
Journal Article